BioHealth News Archive
REGENXBIO Announces Orphan Drug Designation Granted to RGX-202, a Novel Gene Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy
ROCKVILLE, Md., Nov. 22, 2021 /PRNewswire/ -- Potential one-time gene therapy for the treatment of Duchenne, includes a novel, optimized microdystrophin transgene and REGENXBIO's proprietary NAV® AAV8…
Read MoreTop 10 RNA-Based Biopharmas
In institutions and companies, investigators spent some two decades working on RNA-based drugs and vaccines before COVID-19 afforded many of them an opportunity to apply…
Read MoreThese 12 startups are entering the Baltimore-based Techstars Equitech Accelerator – Technical.ly Baltimore
The first cohort of the Techstars Equitech Accelerator is bringing global startups to Baltimore, and supporting companies already growing from a base in the…
Read MoreStudy aiming to define acute traumatic encephalopathy (ATE) published by leading neurology journal | VirginiaBio
BrainBox HeadSmart II Study Investigators Aim to Provide Clinicians with First-Ever Biomarkers and other Functional measurements for Acute Traumatic Encephalopathy (ATE.) A clinical trial…
Read MoreTEDCO Generates $2.3 Billion in Economic Benefits to the State of Maryland and Supports 10,433 Maryland Jobs, According to New Independent Study
COLUMBIA, Md., Nov. 17, 2021 /PRNewswire/ -- TEDCO, Maryland's economic engine for technology companies, announced today the findings of an independent study detailing the impact of…
Read MoreMontgomery Establishes Small Business Accelerator Program with M&T Bank – Conduit Street
Montgomery County announced that it has collaborated with M&T Bank to establish a Small Business Accelerator Program to aid minority business owners. The Montgomery County…
Read MoreMaryland Today | UMD Ranks Among Top 10 Schools for Entrepreneurship…
The University of Maryland secured its place among the nation’s top schools for entrepreneurship in new rankings that reflect its commitment to innovation education…
Read MoreAlexandria Real Estate Equities, Inc. Is Leading the Integration of Mission-Critical R&D and Next-Gen Manufacturing for Companies in Research Triangle That Are Developing Targeted Gene and Cell Therapies and Other Complex Medicines
PASADENA, Calif. and DURHAM, N.C., Nov. 16, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured…
Read MoreHealth IT Panel Focuses on Leveling the Playing Field for Women in Healthcare Leadership – Children’s National
Although women account for nearly half of entry-level jobs in the healthcare industry, female clinician-scientist executives continue to be sparse among healthcare leadership ranks.…
Read MoreDeka Biosciences Raises USD 20 Million in Series A Financing
GERMANTOWN, Md., Nov. 16, 2021 /PRNewswire/ -- Maryland-based biotech company Deka Biosciences ("Deka") today announced that it has successfully closed a USD 20 Million…
Read More935 Prose – The Next Evolution in Innovation.
935 Prose is a 10-story trophy-class, state-of-the-art research/lab building that marries iconic design, and superior lab functionality. It is positioned to recruit and retain…
Read MoreEmmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research
ROCKVILLE, Md., Nov. 15, 2021 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical…
Read MoreTwinLabs in Rockville Fills Up With Four New Tenants – Commercial Observer
The first phase of TwinLabs, a life sciences complex in Rockville, Md., has been fully pre-leased, with four companies taking the entire 25,000 square…
Read MoreMaking The Impossible Possible: A Conversation With Martine Rothblatt
In this riveting What’s Ahead conversation you’ll hear how Martine Rothblatt, creator of SiriusXM, left the communications field entirely to hunt for a cure…
Read More